---
title: "Northland Securities Reaffirms Their Buy Rating on Marchex (MCHX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293442602.md"
description: "Northland Securities analyst Michael Latimore reaffirmed a Buy rating on Marchex (MCHX) with a $4.00 price target, despite shares closing at $1.80. The analyst consensus remains a Moderate Buy with an average target of $4.00. Latimore, a 4-star analyst in the Technology sector, maintains this positive outlook."
datetime: "2026-07-22T06:57:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293442602.md)
  - [en](https://longbridge.com/en/news/293442602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293442602.md)
generator: "portal-rs"
---

# Northland Securities Reaffirms Their Buy Rating on Marchex (MCHX)

Northland Securities analyst Michael Latimore maintained a Buy rating on Marchex yesterday and set a price target of $4.00. The company’s shares closed yesterday at $1.80.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Latimore is a 4-star analyst with an average return of 6.1% and a 32.72% success rate. Latimore covers the Technology sector, focusing on stocks such as Ondas, Gorilla Technology Group Inc., and NICE.

Currently, the analyst consensus on Marchex is a Moderate Buy with an average price target of $4.00.

### Related Stocks

- [MCHX.US](https://longbridge.com/en/quote/MCHX.US.md)
- [ONDS.US](https://longbridge.com/en/quote/ONDS.US.md)
- [GRRR.US](https://longbridge.com/en/quote/GRRR.US.md)
- [NICE.US](https://longbridge.com/en/quote/NICE.US.md)
- [GRRRW.US](https://longbridge.com/en/quote/GRRRW.US.md)

## Related News & Research

- [Marchex Earnings Call: Archenia Deal Fuels Aggressive Outlook](https://longbridge.com/en/news/296715058.md)
- [Marchex (MCHX) Receives a Buy from Northland Securities](https://longbridge.com/en/news/295810897.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [Lowe’s Earns Buy Rating as Strong Earnings and Cash Generation Offset Lower-End Guidance](https://longbridge.com/en/news/296383656.md)
- [Telsey Advisory Reaffirms Their Buy Rating on TJX Companies (TJX)](https://longbridge.com/en/news/296370224.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**